Abstract
The methanol extract from Salvia miltiorrhiza Bungee showed a suppressive effect on umu gene expression of the SOS response in Salmonella typhimurium TA1535 / pSK1002 against the mutagen, Trp-P-1, which requires liver metabolizing enzyme. The methanol extract was successively re-extracted with dichloromethane, butanol, and water. Three suppressive compounds were isolated by SiO2 column chromatography from dichloromethane fraction and identified as tanshinone IIA (1), tanshinone I (2) and Cryptotanshinone (3) by GC, GC-MS, 1H- and 13C-NMR spectroscopy. Compounds 1, 2 and 3 inhibited the SOS-inducing activity of Trp-P-1 in the umu test. Gene expression was suppressed by 76%, 96% and 81% at less than 0.18 μmol / mL, 9 respectively. The ID50 (50% inhibition dose) values were 0.03 μmol / mL 0.008 μmol / mL and 0.010 μmol / mol, respectively. These compounds were assayed with activated Trp-P-1. Compound 2 showed suppressive effect of SOS-inducing activity of activated Trp-P-1 but compounds 1 and 3 did not.
Keywords: salvia miltiorrhiza bunge, diterpenoid, tanshinone, sos response, umu test, antimutagen
Letters in Drug Design & Discovery
Title: Suppressive Components in Salvia miltiorrhiza Against Trp-P-1 and Activated Trp-P-1-Induced SOS Response Using Salmonella typhimurium TA1535 / pSK1002 Umu Test
Volume: 1 Issue: 1
Author(s): Yoshiharu Okuno and Mitsuo Miyazawa
Affiliation:
Keywords: salvia miltiorrhiza bunge, diterpenoid, tanshinone, sos response, umu test, antimutagen
Abstract: The methanol extract from Salvia miltiorrhiza Bungee showed a suppressive effect on umu gene expression of the SOS response in Salmonella typhimurium TA1535 / pSK1002 against the mutagen, Trp-P-1, which requires liver metabolizing enzyme. The methanol extract was successively re-extracted with dichloromethane, butanol, and water. Three suppressive compounds were isolated by SiO2 column chromatography from dichloromethane fraction and identified as tanshinone IIA (1), tanshinone I (2) and Cryptotanshinone (3) by GC, GC-MS, 1H- and 13C-NMR spectroscopy. Compounds 1, 2 and 3 inhibited the SOS-inducing activity of Trp-P-1 in the umu test. Gene expression was suppressed by 76%, 96% and 81% at less than 0.18 μmol / mL, 9 respectively. The ID50 (50% inhibition dose) values were 0.03 μmol / mL 0.008 μmol / mL and 0.010 μmol / mol, respectively. These compounds were assayed with activated Trp-P-1. Compound 2 showed suppressive effect of SOS-inducing activity of activated Trp-P-1 but compounds 1 and 3 did not.
Export Options
About this article
Cite this article as:
Okuno Yoshiharu and Miyazawa Mitsuo, Suppressive Components in Salvia miltiorrhiza Against Trp-P-1 and Activated Trp-P-1-Induced SOS Response Using Salmonella typhimurium TA1535 / pSK1002 Umu Test, Letters in Drug Design & Discovery 2004; 1 (1) . https://dx.doi.org/10.2174/1570180043485635
DOI https://dx.doi.org/10.2174/1570180043485635 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Examination of Hippocampal Differences Between Alzheimer Disease, Amnestic Mild Cognitive Impairment and Normal Aging: Diffusion Kurtosis
Current Alzheimer Research CD123: A Novel Biomarker for Diagnosis and Treatment of Leukemia
Cardiovascular & Hematological Disorders-Drug Targets Dural Venous Sinuses: What We Need to Know
Current Medical Imaging TGF-β2 Signaling in High-Grade Gliomas
Current Pharmaceutical Biotechnology Medication Adherence of Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis Considering the Psychosocial Factors, Health Literacy and Current Life Concerns of Patients
Current Rheumatology Reviews Biology of Circulating Nucleic Acids and Possible Roles in Diagnosis and Treatment in Diabetes and Cancer
Infectious Disorders - Drug Targets Renal Function, Albumin-Creatinine Ratio and Pulse Wave Velocity Predict Silent Coronary Artery Disease and Renal Outcome in Type 2 Diabetic and Prediabetic Subjects
Current Hypertension Reviews Editorial (Hot Topic:Human Pluripotent Stem Cells in Regenerative and Personalized Medicine)
Current Molecular Medicine Alzheimer’s Disease and Antioxidant Therapy: How Long How Far?
Current Medicinal Chemistry HCN Channel as Therapeutic Targets for Heart Failure and Pain
Current Topics in Medicinal Chemistry Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives
Current Stem Cell Research & Therapy Inflammatory Cytokines in Acute Ischemic Stroke
Current Pharmaceutical Design Early Detection of Epileptic Seizures in Sparse Domains
Neuroscience and Biomedical Engineering (Discontinued) Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus
Current Cardiology Reviews Endothelial Cell Regulation of Cardiac Metabolism Following Diabetes
Cardiovascular & Hematological Disorders-Drug Targets Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Asymmetric Dimethylarginine as a Biomarker in Coronary Artery Disease
Current Topics in Medicinal Chemistry Combined Angiogenic and Osteogenic Factor Delivery for Bone Regenerative Engineering
Current Pharmaceutical Design Recent Advances in α1-Adrenoreceptor Antagonists as Pharmacological Tools and Therapeutic Agents
Current Topics in Medicinal Chemistry High Risk of One-year Stroke Recurrence in Patients with Younger Age and Prior History of Ischemic Stroke
Current Neurovascular Research